China Post-marketing Surveillance (PMS) Study of Fabrazyme®
NCT05054387
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Interventions
DRUG:
Agalsidase beta
Sponsor
Genzyme, a Sanofi Company